Cholangiocarcinoma--current treatment options.
1Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden. styrbjorn.friman@surgery.gu.se
Summary
Cholangiocarcinoma (CCA) treatment is challenging due to its aggressive nature and limited options beyond surgery. Early diagnosis and advanced surgical techniques are crucial for improving outcomes in this rare but increasing liver cancer.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Background:
- Cholangiocarcinoma (CCA) is a rare but increasing malignancy of the bile ducts.
- It presents a significant treatment challenge due to its aggressive nature and limited effective therapies.
- Surgical resection (HR) and liver transplantation (LT) are the primary treatment options, but many cases are unresectable at diagnosis.
Purpose of the Study:
- To review the current treatment landscape for cholangiocarcinoma (CCA).
- To highlight the importance of early diagnosis and advanced surgical approaches.
- To discuss emerging treatment protocols and diagnostic modalities.
Main Methods:
- Review of current literature on cholangiocarcinoma (CCA) treatment.
- Analysis of surgical approaches including hepatectomy, liver transplantation (LT), and neoadjuvant therapies.
- Discussion of diagnostic advancements in tumor markers, cytology, and radiology.
Main Results:
- Hepatectomy (HR) is the treatment of choice for intrahepatic CCA.
- Liver transplantation (LT) is essential for cases with concomitant liver disease like cirrhosis or PSC.
- Aggressive surgical strategies, including neoadjuvant chemoradiation and LT, show promising results.
Conclusions:
- Effective medical treatment for CCA is lacking, making radical surgery essential.
- Early detection through improved diagnostic modalities is critical for successful surgical intervention.
- Further research is needed to confirm the efficacy of combined neoadjuvant therapies and liver transplantation (LT).
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...